General Gastro News Articles

Gastro

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kim N et al. – The 7–day moxifloxacin–containing triple therapy produced an unacceptably low eradication rate. Increasing the duration of therapy was expected to increase the eradication rate, but the expected increased did not materialize, most likely because of coincident marked increase in the prevalence of resistance to moxifloxacin. Tailored treatment based on antibiotic susceptibility testing might be more effective in the achievement of high eradication rate when rapid antibiotic resistance such as moxifloxacin is occurring.

Today in Pharmacology/kinetics...keeping you current

Usefulness of reagent strips for checking cure in spontaneous bacterial peritonitis after short-course treatment
Alimentary Pharmacology and Therapeutics, 12/07/09

Mercaptopurine rescue after azathioprine-induced liver injury in inflammatory bowel disease
Alimentary Pharmacology and Therapeutics, 12/07/09

The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
Alimentary Pharmacology and Therapeutics, 12/07/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address